David Domzalski Net Worth & Insider Trades

David Domzalski - President and CEO, Vyne Therapeutics Inc

As of December 4, 2023

What is David Domzalski's Net Worth?

The current estimated net worth of Vyne Therapeutics Inc's President and CEO, David Domzalski, is estimated to be about $822.62K . David Domzalski owns about 1,315,966 units of Vyne Therapeutics Inc common stock. In the last 3 years at Vyne Therapeutics Inc, David Domzalski has sold an estimated value of $228.64K worth.

What is David Domzalski's Past Insider Trading?

David Domzalski's largest purchase order was 75,000 units , worth over $103.57K on September 8, 2020. In total, David Domzalski has made about 24 transactions over 3 years of their time at Vyne Therapeutics Inc. David Domzalski usually trades in December and October, with the busiest year in 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

David Domzalski

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is David Domzalski's' Mailing Address?

  • Mailing address is C/o Foamix Pharmaceuticals Ltd. 2 Holzman Street, Weizmann Science Park Rehovot L3 76704 Israel

What are Vyne Therapeutics Inc's Past Insider Trades?

Vyne Therapeutics Inc's most recent insider trade came on November 17, 2023 by Patrick G Lepore who bought 13,000 units worth $50.78K . In the last 3 years, insiders at Vyne Therapeutics Inc have sold an estimated value of $5.69M and bought an estimated value of $10.64M worth of shares. Insider trading is most common in July, with the busiest year in 2021. The most active traders at the company are David Domzalski, President and CEO,  Mutya Harsch, Chief Legal Officer and GC,  and Iain Stuart, Chief Scientific Officer .

VYNE Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...